Form EFFECT Acurx Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 11, 2026 4:01 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acurx Pharmaceuticals Announces Scientific Poster Presentation of Ibezapolstat's Microbiome Preservation Data in Multiply-recurrent C. difficile Infection
- Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Provides New Details on FF’s EAI Data Factory, Q3 “Four-Core Full-Stack AI” Robotics Practical Deployment Campaign and
- Chainlink Price Prediction Points to Growth as Pepeto Builds an Early Window Below a Cent
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
